EuroStemCell Connect - stem cell projects in Europe

We work closely with other EU-funded stem cell projects, coordinating efforts to engage with the public about our science. Click the logos below to read more about the projects. You can see our extended network of research institutes and projects on our stem cell map of Europe.
project logo

The VISICORT (Adverse Immune Signatures and their Prevention in Corneal Transplantation) project is focussed on understanding adverse immune responses to corneal transplantation. The final year of the project will involve a clinical trial using stem cells to modify the immune response to transplantation with the aim of improving outcomes for transplant recipients.

project logo

Neurostemcellrepair (European stem cell consortium for neural cell replacement, reprogramming and functional brain repair) is formed to create a world-leading consortium that aims at taking human stem cells through the final steps toward clinical application in cell replacement therapy. Neurostemcellrepair is expected to close the gap between development and clinical implementation of stem cell replacement therapies for Parkinson’s Disease (PD) and make significant advance towards stem cell therapy in Huntington’s Disease (HD).

project logo

A consortium of 10 European partners have been awarded €6million by the European Commission for a research and development project focused on directing stem cells to become bone and muscle.

project logo

ThymiStem is the European Consortium for Development of Stem Cell-Based Therapy for Thymic Regeneration. Nine research teams from seven countries are working towards stem cell therapies that can boost the immune system by repairing the thymus, an essential organ of the immune system.  

project logo

The HumEn project brings together six leading European stem cell-research groups and three industrial partners in a coordinated and collaborative effort aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes.

project logo

STELLAR is a research consortium consisting of European and Australian researchers interested in developing an alternative to renal replacement therapy. The STELLAR consortium will make use of newly discovered kidney mesenchymal stromal cells that have the potential to regenerate and repair damaged tissue.

project logo

REDDSTAR, Repair of Diabetic Damage by Stromal Cell Administration, is an EU funded project which will develop and test bone marrow derived stromal cell therapy to treat diabetes mellitus. The objective is to control blood glucose while also addressing a range of six diabetic complications.

project logo

The goal of the HEALING project is to uncover how stem cells influence the regeneration of cells and tissues. However, the aims of HEALING are about more than just understanding. We will develop new chemical substances to improve cell regeneration and wound-healing and ultimately to benefit patients with degenerative diseases or chronic wounds like ulcers.

 

project logo

CardioCell aims to identify sources of cells that can be used to regenerate injured heart tissue. We are expanding our basic scientific knowledge about cardiomyocyte progenitors - a type of cell that produces heart muscle cells (cardiomyocytes). The new knowledge we generate will contribute to significant improvements in the prevention and treatment of cardiovascular diseases in Europe, and will help to maintain European competitiveness in this field of research.

project logo

EuroSyStem - the European Federation for Systematic Stem Cell Biology - is an EU Framework 7 partnership. EuroSyStem aims to drive the generation of new knowledge on the characteristics of normal and abnormal stem cells by interconnecting biological and computational expertise. EuroSystem completed its four years of activity in 2012.

project logo

NeuroStemcell - the European Consortium for Stem Cell Therapy in Neurodegenerative Diseases - is an EU Framework 7 partnership. NeuroStemcell combines the expertise of 13 academic partners and three small-to-medium businesses from six countries. Its research focuses on stem-cell-based therapies for Parkinson’s and Huntington’s diseases. NeuroStemcell completed its four years of activity in 2013.

project logo

ESTOOLS, a Framework 6 Integrated Project, aimed to develop the tools and knowledge required for application of human embryonic stem (ES) cells in industry and medicine. It was the largest consortium of researchers studying human ES cells in Europe. The project teamed up 21 research groups, bringing together more than 150 scientists in 10 countries. It was the first EU-funded project focused entirely on human embryonic stem cells.  ESTOOLS completed its 4 years of activity in July 2010.  

project logo

OptiStem brings stem cell biology and clinical science together in a drive to develop and test new stem-cell-based approaches to therapy. We are focussed on degenerative diseases of the skeletal muscle, and repair of diseased or damaged epithelial tissues such as the skin or cornea. OptiStem completed is four years of activity in February 2014.